New minimally invasive device may soon replace endoscopy for Barrett's esophagus diagnosis
the ONA take:
According to a new study published in the journal PLOS Medicine, reseearchers from the University of Cambridge MRC Cancer Unit in Cambridge, United Kingdom, have found that a new minimally invasive test can be used to identify patients with reflux symptoms to diagnose Barrett's esophagus rather than be referred for endoscopy for diagnosis.
For the study, researchers sought to evaluate the accuracy, safety, and acceptability of the test compared with endoscopy for the diagnosis of Barrett's esophagus, a disorder characterized by an abnormal change in the cells of the lower part of the esophagus that is a risk factor for the development of esophageal cancer.
Researchers enrolled 1,110 patients from various hospitals in the United Kingdom who were referred for a diagnostic endoscopy for symptoms of dyspepsia and reflux symptoms.
Results showed that the new minimally invasive test accurately diagnosed 79.7% of the 647 patients with endoscopically diagnosed Barrett's esophagus, and correctly identified 92.4% of 463 of those unaffected by Barrett's esophagus as not having Barrett's esophagus.
Researchers found that the test had an 87.2% sensitivity when patients had a circumferential Barrett's segments over 3cm. Most patients were able to swallow the device without issues and no adverse events were observed.
A new minimally invasive test can be used to identify patients with reflux symptoms to diagnose Barrett's esophagus.
Sign Up for Free e-newsletters
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|